A detailed history of Rpo LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Rpo LLC holds 338,542 shares of HQL stock, worth $4.77 Million. This represents 12.47% of its overall portfolio holdings.

Number of Shares
338,542
Previous 338,542 -0.0%
Holding current value
$4.77 Million
Previous $4.56 Million 1.27%
% of portfolio
12.47%
Previous 7.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$11.35 - $13.6 $130,525 - $156,400
11,500 Added 3.52%
338,542 $4.56 Million
Q3 2023

Nov 06, 2023

BUY
$12.38 - $13.69 $1.74 Million - $1.93 Million
140,942 Added 75.73%
327,042 $4.08 Million
Q2 2023

Aug 09, 2023

BUY
$13.13 - $14.17 $2.44 Million - $2.64 Million
186,100 New
186,100 $2.52 Million

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Rpo LLC Portfolio

Follow Rpo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rpo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rpo LLC with notifications on news.